866-997-4948(US-Canada Toll Free)

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017

Published By :

GlobalData

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 1178 Pages

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 27
In Progress Trials by Phase 28
Clinical Trials by Trial Status 29
Clinical Trials by End Point Status 31
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials 36
Prominent Drugs 38
Latest Clinical Trials News on Chronic Kidney Disease (Chronic Renal Failure) 40
Jun 12, 2017: Jardiance (Empagliflozin) Tablets To Be Studied In Chronic Kidney Disease 40
Jun 09, 2017: Zytoprotec's Novel Dialysis Product Meets Both Endpoints in Phase II Study 40
Jun 06, 2017: Dimerix hosts US key opinion leader meeting with NephCure Kidney International focused on development path of DMX-200 in kidney disease 41
May 31, 2017: Resverlogix To Host Epigenetics Focused Symposium At The ERA-EDTA Congress in Madrid, Spain 41
May 15, 2017: Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Requested Apabetalone Clinical Trial 42
Clinical Trial Profile Snapshots 43
Appendix 1176
Abbreviations 1176
Definitions 1176
Research Methodology 1177
Secondary Research 1177
About GlobalData 1178
Contact Us 1178
Source 1178

List of Tables
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region, 2017* 8
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 18
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 21
Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 23
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 26
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Phase, 2017* 27
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 28
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 30
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 33
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 35
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 37
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 39

List of Figures
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 17
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 22
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 27
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 28
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 33
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38
GlobalData Methodology 1177

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *